Loading...
XJPX
6848
Market cap103mUSD
Oct 09, Last price  
842.00JPY
1D
0.24%
1Q
-1.06%
Jan 2017
58.87%
Name

DKK-Toa Corp

Chart & performance

D1W1MN
XJPX:6848 chart
P/E
17.38
P/S
0.92
EPS
48.45
Div yield, %
2.62%
Shrs. gr., 5y
-0.13%
Rev. gr., 5y
2.18%
Revenues
17.81b
-1.38%
15,254,000,00013,905,000,00012,681,000,00013,734,000,00014,357,000,00013,672,000,00013,923,000,00014,066,000,00014,326,000,00014,445,000,00015,605,000,00017,548,000,00016,349,000,00015,988,000,00016,424,000,00016,540,000,00017,444,000,00018,058,000,00017,809,000,000
Net income
945m
-15.09%
538,000,000401,000,000503,000,0001,096,000,000781,000,000878,000,000881,000,000759,000,000931,000,0001,226,000,0001,230,000,0001,322,000,0001,369,000,0001,374,000,0001,347,000,0001,218,000,0001,292,000,0001,113,000,000945,000,000
CFO
2.38b
+29.72%
413,000,000743,000,0001,414,000,000308,000,000486,000,0001,470,000,000948,000,0001,259,000,000988,000,0001,116,000,000995,000,0001,849,000,0001,074,000,0001,809,000,0001,492,000,000307,000,000165,000,0001,837,000,0002,383,000,000
Dividend
Mar 30, 202722 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Founded in Tokyo, Japan, in 1944, Dkk-Toa Corporation is an international enterprise specializing in the development, manufacturing, and distribution of a wide array of measuring and analytical instrumentation. Their comprehensive product portfolio includes laboratory, portable, and handheld analyzers, as well as specialized devices for industrial, environmental, and medical applications. The company also supplies sophisticated process analyzers and bespoke solutions for critical areas like water and wastewater treatment, boiler water systems, and oil refineries. Furthermore, Dkk-Toa provides advanced water quality monitoring systems, ambient air and emission gas analyzers, and equipment for measuring pH and oxidation-reduction potential (ORP). Beyond its core instrumentation business, the corporation produces and markets various toxic and deleterious chemical agents and reagents. Additionally, Dkk-Toa engages in contracting services for instrumentation, electrical, and telecommunications projects, and operates a real estate rental division.

Key people

Kazuyuki Takashima
President, Representative Director · since 2025
Yuji Yamagishi
Director, Chief Director of Overseas Sales · since 2025
Masami Abiko
Executive Officer, Director of Business Stratgey · since 2022
Keiichiro Daimi
Executive Officer · since 2022
Toshio Saito
Executive Officer · since 2022
Toru Uchida
Executive Officer · since 2022
Toru Kosaka
Managing Director, Chief Director of Administration · since 2026
Hajime Kudo
Chief Director of Production, Manager of Saitama Center, Director · since 2025
Satoshi Arakawa
Chief Director of Development Technology Director of Biochemical Technology, Director · since 2024
Sadakatsu Maru
Director · since 2017
Takashi Nishizawa
Deputy Chief Director of Main Development Engineering Unit, Director of Water Quality Engineering, Director · since 2023
Masao Shoji
Director · since 2024
Toshio Takahashi
President, Representative Director · since 2017
Susumu Taniyama
Chief Director of Domestic Sales, Director · since 2020
Nozomi Azuma
Independent Director · since 2021
Jinichi Igarashi
Independent Director · since 2022
IPO date
Nov 02, 1961
Employees
569
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT